Beta Bionics, Inc. Common Stock (BBNX) — Net Asset Quality Index
Beta Bionics, Inc. Common Stock (BBNX) has a Net Asset Quality Index of 87.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $292.39 Million minus total liabilities of $36.02 Million yields net assets of $256.37 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read BBNX total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beta Bionics, Inc. Common Stock Net Asset Quality Index Over Time (2022–2025)
This chart shows how Beta Bionics, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 87.7%, representing net assets of $256.37 Million against total assets of $292.39 Million USD. For live market cap and overall valuation, see how much is Beta Bionics, Inc. Common Stock worth.
Annual Net Asset Quality Index for Beta Bionics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BBNX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.5% | $287.61 Million | $328.74 Million | $41.13 Million | ▲ +36.7 pp |
| 2024 | 50.8% | $76.01 Million | $149.65 Million | $73.63 Million | ▼ -2.5 pp |
| 2023 | 53.3% | $58.61 Million | $110.04 Million | $51.43 Million | ▲ +531.9 pp |
| 2022 | -478.6% | $-170.03 Million | $35.53 Million | $205.56 Million | — |